What Researchers Did
Researchers conducted a review of past clinical and experimental studies to understand the role of hyperbaric oxygen therapy (HBOT) for inflammatory bowel disease (IBD).
What They Found
The review suggested that hyperbaric oxygen therapy (HBOT) can be an effective adjunctive approach for inflammatory bowel disease (IBD). HBOT was found to exert therapeutic effects by controlling inflammation, reducing oxidative stress, improving cellular repair, and enhancing the immune response system.
What This Means for Canadian Patients
Canadian patients with inflammatory bowel disease might potentially benefit from hyperbaric oxygen therapy as an additional treatment option to conventional therapies. This could lead to improved management of inflammation and symptoms, although further research is needed to establish its widespread clinical application.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review, this study's findings are dependent on the quality and heterogeneity of the included past clinical and experimental studies.